SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

: Emerging Challenges in Primary Care Fort Lauderdale, FL
Activity/Course #:
: 01.20.18PC

: Free
Release/Start Date:
: Jan 20 2018
Expiration Date:
: Jan 20 2018
: Primary Care Medicine
Target Audience:
: Primary Care Providers
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 2.75 pharmacology hour(s)
Hardware/Software Requirements:

Fort Lauderdale Marriott Coral Springs
11775 Heron Bay Blvd
Coral Springs, FL 33076
(954) 753-5598

Registration Fee

There is no registration fee for this activity.

Special Accommodations 

NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking

Complimentary self-parking is available at the hotel.

Hotel Guest Rooms

NACE has reserved a sleeping room rate of $149 per night at the Fort Lauderdale Marriott Coral Springs. To reserve your room at this rate, call reservations at 1-800-228-9290 and ask for the NACE room block by December 29, 2017.

Program Summary

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives
At the conclusion of this program, participants should be able to:

1. Describe the role of the kidney in glucose metabolism in health and disease; Review the physiologic effects and clinical efficacy of SGLT-2 therapy in various patient populations; Review emerging data on possible renal and macrovascular effects of evidence-based diabetes treatment options; Integrate the impact of treatment decisions on postprandial hyperglycemia and risk of hypoglycemia.

2. Differentiate adrenal gland disorders and classify them as either hyperfunctioning or hypofunctioning based on the provided clinical and laboratory information; Recognize the preferred treatment option(s) for specific adrenal gland disorders; Prepare a patient-specific monitoring plan for medications used in the management of adrenal gland disorders and anticipate new medication-related problems.

3. Describe the role of persistent oncogenic HPV in the development of pre-cancer and cancer of the cervix; Describe the use of HPV testing as co-testing along with the Pap in cervical cancer screening for women 30 and older; Describe the use of HPV primary screening in women 25 and older; Describe 3 important messages that clinicians will teach women regarding HPV infection.

4. Discuss the diagnosis of osteoporosis and low bone mass; Discuss the role of non-pharmacologic agents in the prevention of bone fracture; Discuss the pharmacologic treatment of low bone mass and osteoporosis; Discuss the current controversies in management of osteoporosis.

5. Describe strategies of care in COPD to improve diagnosis and ongoing symptom assessment; Tailor COPD pharmacotherapy according to current guidelines while incorporating unique patient needs and characteristics; Discuss the appropriate use of inhaled therapies for COPD, including the importance of proper inhaler technique; Collaborate with members of interprofessional health care team for effective chronic disease management.

6. Define Patient Experience & How to Measure it; Describe today’s Healthcare World; Outline the importance of the Patient Experience; Understand & apply the H.E.L.P. communication method.


7:30-8:00   Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Gregg Sherman, MD

Integrating Data on Macrovascular and Microvascular Outcomes into Diabetes Management: Evolving Treatment Strategies
Mark Stolar, MD


Primary Care Endocrinology: The Adrenal and Pituitary Herding Horses and Zebras
Mark Stolar, MD

10:30-10:50   Break
10:50-12:00   Cervical Cancer Screening: Appropriate Use of Pap & HPV Testing
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP


1:00-2:10   Osteoporosis and Fracture Prevention Strategies
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP
 2:10-3:20   The Evolving Landscape of COPD: Strategies to Optimize Care and Improve Outcomes
Franck Rahaghi, MD, MHS, FCCP
 3:20-3:30   Break

Targeting the Patient Experience
Marlene R. Wolf, MD, FAAFP


Program Summary and Closing Remarks
Gregg Sherman, MD

 *Agenda subject to change.


Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP
Adult Nurse Practitioner
Certified Menopause Practitioner
Millennium Affiliated Physicians
Division of Michigan Healthcare Professionals
Farmington Hills, MI

Mark Stolar, MD
Associate Professor of Clinical Medicine
Feinberg School of Medicine
Northwestern University
Chicago, IL

Franck Rahaghi, MD, MHS, FCCP
Director of Advanced Lung Disease Clinic
Director, Pulmonary Hypertension Clinic
Head of Alpha-1 Foundation Clinical Resource Center
Chairman, Dept. of Pulmonary and Critical Care
Cleveland Clinic Florida
Weston, FL          

Marlene R. Wolf, MD, FAAFP
Clinical Assistant Professor of Family Medicine
Nova Southeastern University's College of Allopathic Medicine
Family Practice
Lifetime Medical Consulting, LLC
Coral Springs, FL

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education
Plantation, FL

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education
Plantation, FL

Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7 contact hours of continuing education (which includes 2.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
Emerging Challenges in Primary Care: 2017 is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.; and an independent medical educational grant from Sunovion Pharmaceuticals, Inc.